A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis

Clinical trial NCT06138132 · RECRUITING

Trial details

NCT number: NCT06138132
Sponsor: Stanford University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive

Start date: 2024-04-10
Primary completion: 2027-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.